We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Global PCR and Real-Time PCR Testing Market Driven by Need for Early Disease Detection

By LabMedica International staff writers
Posted on 09 Sep 2022

The polymerase chain reaction (PCR) and real-time polymerase chain reaction testing market consists of sales of PCR and real-time PCR testing services and related products. More...

The real-time RT-PCR technique is a highly sensitive and specific testing method that can deliver a reliable diagnosis in as fast as three hours, unlike the other laboratory tests that take an average of 6 to 8 hours. Real-time RT-PCR is significantly faster and has a lower potential for contamination or errors as the entire process is within a closed tube. With the onset of chronic diseases, there is focus on detecting the cause of the disease to decrease its onset on people, for drug discovery and for starting the appropriate treatment at the appropriate time, which enables faster cure, saves maximum lives and decreases after-effects.

Early detection plays a key role in treating COVID-19 patients. Real-time RT-PCR is considered to be the most accurate method available for the detection of coronavirus. The RT-PCR test is the standard test for coronavirus and is used for its high sensitivity, which enables it to detect early infection. This has created a huge demand for PCR testing kits. Thus, the need for early detection of COVID-19 is driving the growth of the PCR and real-time PCR testing market. Additionally, most companies are coming up with real-time RT-PCR tests for coronavirus, thus contributing to the market growth. The global PCR and real time PCR testing market is expected to grow at a CAGR of 6.2% from USD 18.5 billion in 2021 to USD 19.64 billion in 2022 and further grow to USD 24.61 billion in 2026 at a CAGR of 5.8%. In 2021, Asia Pacific was the largest PCR and real-time PCR testing market, followed by Western Europe.

These are the latest findings of Research and Markets (Dublin, Ireland), a market research firm.

The players operating in the PCR and real-time PCR testing market manufacture, develop, or deploy related devices, reagents, and services, to detect and measure DNA (or RNA) in a sample. PCR and real-time PCR testing find applications in cloning, genotyping, mutation testing, paternity testing, sequencing, and microarrays. The main products involved in PCR and real-time PCR testing are consumables and reagents, instruments, and software and services. The technologies involved in PCR and real-time PCR testing are quantitative PCR and digital PCR that find various applications such as clinical diagnostics, life science research, industrial applications, and others. The need for early detection of diseases is expected to continue driving the global PCR and real time PCR testing market. The players operating in the PCR and RT PCR testing market are coming up with new test kits and systems for the diagnosis of diseases. However, the development of alternative technologies such as CRISPR is expected to hinder market growth.

Related Links:
Research and Markets 


New
Gold Member
Latex Test
SLE-Latex Test
New
Gold Member
Thyroid-Stimulating Hormone Test
ULTRA-TSH
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
New
C-Reactive Protein Rapid Test
Afinion CRP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Molecular Diagnostics

view channel
Image: The new study findings emphasize the need for incorporating disease heterogeneity into type 2 diabetes care strategies (Photo courtesy of Cell 2025; doi.org/10.1016/j.cell.2025.05.00)

Molecular Fingerprint for Insulin Sensitivity Could Diagnose Diabetes Before Disease Develops

Insulin is a hormone essential for regulating blood sugar levels, and its dysfunction is a key factor in the development of diabetes. Insulin resistance, a condition where the body's cells do not respond... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: Results of AI-based 3D virtual H&E staining and quantitative analysis of pathological tissue (Photo courtesy of Nature Communications, DOI:10.1038/s41467-025-59820-0)

Virtual Staining Technology Paves Way for Non-Invasive Pathological Diagnosis

For more than 200 years, traditional pathology has depended on the technique of examining cancer tissues under a microscope, a method that provides only limited, specific cross-sections of the 3D structure... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.